Skip to main content

Table 4 Main clinical and immunohematological characteristics of Dercum’s disease (DD) and Roch-Leri lipomatosis (LMS) groups compared to an obese control group

From: Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis

Metabolic characteristics

Dercum(n = 9)

LMS(n = 11)

Obese controls(n = 8)

p DD versus obese

p LMS versus obese

p obese versus lean

Clinical data

      

Sex ratio (M/W)

0.5 (3 M/6F)

1.75 (7 M/4F)

0.5 (4 M/4F)

 > 0.99

 > 0.99

0.09

Age (years)

30.8 [16–50]

31.2 [18–68]

46.5 [23–64]

0.44

0.21

 > 0.99

BMI (kg/m2)

32 [27–59]

31 [25–35]

34.1 [31–43]

 > 0.99

 > 0.99

0.002

Treated hypertension (%; n/N)

22% (2/9)

64% (7/11)

38%(3/8)

 > 0.99

 > 0.99

0.27

Diabetes (%; n/N)

33% (3/9)

9% (1/11)

25% (2/8)

 > 0.99

 > 0.99

0.75

Treated dyslipidemia (%; n/N)

11% (1/9)

45% (5/11)

38% (3/8)

 > 0.99

 > 0.99

0.22

Paraclinica

      

Hemoglobin (g/dL)

14.3 [12.5–15.4]

14.6 [12–15.4]

14.9[12.8–16.6]

0.47

 > 0.99

 > 0.99

Platelets (103/mm3)

266 [211–310]

220 [104–255]

242 [221–283]

0.8

0.51

0.09

Leukocytes (103/mm3)

7.8 [5–9.1]

5.8 [5.2–9.8]

6.9 [5.1–11.3]

0.97

0.74

0.06

CRP (mg/L)

3 [3–18]

3 [3–10]

6.3 [3–10]

 > 0.99

 > 0.99

 > 0.99

Leukocyte differential: (/mm3)

      

Lymphocytes

1939 [1100–2000]

1832 [600–2300]

2141 [1500–3300]

0.71

0.46

0.97

Monocytes

500 [500–700]

400`[400–600]

400 [300–700]

 > 0.99

 > 0.99

 > 0.99

Nuclear neutrophils

5200 [2600–10000]

3300 [2500–4600]

4050 [2600–7100]

 > 0.99

 > 0.99

0.16

Eosinophils

150 [0–300]

100 [0–500]

188 [100–400]

 > 0.99

0.35

 > 0.99

Basophils

52 [30–100]

19 [0–37]

22 [0–100]

0.03

0.97

0.14

Lymphocytes subpopulations (n/N)

(5/9)

(7/11)

(8/8)

   

CD3+

1420 [1105–1904]

867 [513–1584]

1688[1215–1982]

0.94

0.02

0.84

CD4+

1255 [790–1710]

636.5 [328–922]

979 [785–1454]

0.96

0.01

0.77

CD8+

479 [454–788]

227[140–310]

493 [209–992]

 > 0.99

0.02

0.89

B Lymphocytes

204.5 [140–760]

227 [101–310]

199 [152–346]

0.73

 > 0.99

 > 0.99

NK Lymphocytes

207.5 [40–225]

210 [124–300]

287 [226–634]

0.06

0.31

 > 0.99

  1. The number of patients studied was indicated only when at least one data point was missing: n: number of examinations performed/ N: total number of patients in the group
  2. *: p < 0.05, **: p < 0.01, ***: p < 0.001, ns: non significant; p > 0.05*: p < 0.05, **: p < 0.01, ***: p < 0.001, ns: non significant